» Articles » PMID: 27129682

Development of a Plasmodium Berghei Transgenic Parasite Expressing the Full-length Plasmodium Vivax Circumsporozoite VK247 Protein for Testing Vaccine Efficacy in a Murine Model

Overview
Journal Malar J
Publisher Biomed Central
Specialty Tropical Medicine
Date 2016 May 1
PMID 27129682
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The approach of using transgenic rodent malaria parasites to assess the immune system's response to antigenic targets from a human malaria parasite has been shown to be useful for preclinical evaluation of new vaccine formulations. The transgenic Plasmodium berghei parasite line [PvCSP(VK210)/Pb] generated previously expresses the full-length circumsporozoite protein (CSP) VK210 from Plasmodium vivax. The transgenic parasite expresses one of the two most common alleles of CSP, defined by nine amino acids at the central repeat region of this protein. In the present study, a transgenic P. berghei parasite line [PvCSP(VK247)/Pb] expressing the full-length PvCSP(VK247), which is the alternative common allele, was generated and characterized.

Methods: The P. berghei expressing full-length PvCSP(VK247) was generated and examined its applicability to CSP-based vaccine research by examining its biological characteristics in mosquitoes and mice.

Results: Similar to PvCSP(VK210)/Pb, PvCSP(VK247)/Pb developed normally in mosquitoes and produced infectious sporozoites equipped to generate patent infections in mice. Invasion of HepG2 cells by PvCSP(VK247)/Pb sporozoites was inhibited by an anti-PvCSP(VK247) repeat monoclonal antibody (mAb), but not by an anti-PvCSP(VK210) repeat mAb.

Conclusions: These two transgenic parasites thus far can be used to evaluate the potential efficacy of PvCSP-based vaccine candidates encompassing the two major genetic variants in preclinical trials.

Citing Articles

A Head-to-Head Comparative Study of the Replication-Competent Vaccinia Virus and AAV1-Based Malaria Vaccine versus RTS,S/AS01 in Murine Models.

Zainal K, Hasyim A, Yamamoto Y, Mizuno T, Sato Y, Rasyid S Vaccines (Basel). 2024; 12(10).

PMID: 39460322 PMC: 11512279. DOI: 10.3390/vaccines12101155.


A two-dose viral-vectored multistage vaccine confers durable protection and transmission-blockade in a pre-clinical study.

Yamamoto Y, Fabbri C, Okuhara D, Takagi R, Kawabata Y, Katayama T Front Immunol. 2024; 15:1372584.

PMID: 38745665 PMC: 11091281. DOI: 10.3389/fimmu.2024.1372584.


Evaluation of two Plasmodium vivax sexual stage antigens as transmission-blocking vaccine candidates.

Zhang Y, Liu F, Zhao Y, Yang F, Bai J, Jia X Parasit Vectors. 2021; 14(1):407.

PMID: 34399829 PMC: 8366161. DOI: 10.1186/s13071-021-04909-w.


Comparative intravital imaging of human and rodent malaria sporozoites reveals the skin is not a species-specific barrier.

Hopp C, Kanatani S, Archer N, Miller R, Liu H, Chiou K EMBO Mol Med. 2021; 13(4):e11796.

PMID: 33750026 PMC: 8033530. DOI: 10.15252/emmm.201911796.


Investigating immune responses to parasites using transgenesis.

Tedla M, Every A, Scheerlinck J Parasit Vectors. 2019; 12(1):303.

PMID: 31202271 PMC: 6570953. DOI: 10.1186/s13071-019-3550-4.


References
1.
Gonzalez J, Hurtado S, Arevalo-Herrera M, Herrera S . Variants of the Plasmodium vivax circumsporozoite protein (VK210 and VK247) in Colombian isolates. Mem Inst Oswaldo Cruz. 2001; 96(5):709-12. DOI: 10.1590/s0074-02762001000500023. View

2.
Mizutani M, Iyori M, Blagborough A, Fukumoto S, Funatsu T, Sinden R . Baculovirus-vectored multistage Plasmodium vivax vaccine induces both protective and transmission-blocking immunities against transgenic rodent malaria parasites. Infect Immun. 2014; 82(10):4348-57. PMC: 4187867. DOI: 10.1128/IAI.02040-14. View

3.
de Koning-Ward T, ODonnell R, Drew D, Thomson R, Speed T, Crabb B . A new rodent model to assess blood stage immunity to the Plasmodium falciparum antigen merozoite surface protein 119 reveals a protective role for invasion inhibitory antibodies. J Exp Med. 2003; 198(6):869-75. PMC: 2194199. DOI: 10.1084/jem.20030085. View

4.
Rosenberg R, Wirtz R, Lanar D, Sattabongkot J, Hall T, Waters A . Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax. Science. 1989; 245(4921):973-6. DOI: 10.1126/science.2672336. View

5.
Kain K, Brown A, Webster H, Wirtz R, Keystone J, Rodriguez M . Circumsporozoite genotyping of global isolates of Plasmodium vivax from dried blood specimens. J Clin Microbiol. 1992; 30(7):1863-6. PMC: 265394. DOI: 10.1128/jcm.30.7.1863-1866.1992. View